Research associated with Research ethics

Publications:

Ethics of sham surgery: Perspective of patients.
Frank S, Holloway RG, Zimmerman C, Peterson DR, Kieburtz K, Kim S. Movement Disorders . In Press, 2007.

Determining when impairment constitutes incapacity for informed consent in schizophrenia research.
Kim S, Leibovici A, Lamberti JS, Jeste DV, Goff DC, McEvoy JP, Stroup S, Swan JG, Appelbaum PS, Caine ED. British Journal of Psychiatry . 191:38-43, 2007.

The capacity to appoint a proxy and the possibility of concurrent proxy directives.
Kim S, Appelbaum PS. Behavioral Sciences and the Law . 24:469-478, 2006.

Volunteering for early phase gene transfer research in Parkinson's disease.
Kim S, Holloway RG, Frank S, Beck CA, Zimmerman C, Wilson R, Kieburtz K. Neurology. 66:1010-1015, 2006.

Appointing a proxy for research consent after one develops dementia: The need for further study.
Kim S, Kieburtz K. Neurology. 66:1298-1299, 2006.

Decision-making capacity for research participation among individuals in the CATIE schizophrenia trial.
Stroup S, Manschreck T, Keefe R, Kim S, Jeste DV, Davis S, Patel M, Swartz M, Appelbaum PS, Lieberman J. Schizophrenia Research . 80:1-8, 2005.

What do people at risk for Alzheimer's disease think about surrogate consent for research?
Kim S, Kim HM, McCallum C, Tariot PN. Neurology. 65:1395-1401, 2005.

Is psychiatric research stigmatized? An experimental survey of the public.
Muroff JR, Hoerauf SL, Kim S. Schizophrenia Bulletin. 32:129-136, 2005.

When does decisional impairment become decisional incompetence? Ethical and methodologial issues in capacity research in schizophrenia.
Kim S. Schizophrenia Bulletin. 32:92-97, 2005.

Science and ethics of sham surgery: A survey of Parkinson disease clinical researchers.
Kim S, Frank S, Holloway RG, Zimmerman C, Wilson R, Kieburtz K. Archives of Neurology . 62:1357-1360, 2005.

What is the risk of sham surgery in Parkinson's disease clinical trials? A review of published reports.
Frank S, Kieburtz K, Holloway RG, Kim S. Neurology. 65:1101-1103, 2005.

The ability of people with Alzheimer disease (AD) to make a decision about taking an AD treatment.
Karlawish JHT, Kim S, Casarett DJ, James BD, Xie S. Neurology. 64:1514-1519, 2005.

Evidence-based ethics in neurology and psychiatry research.
Kim S. NeuroRx. 1:372-377, 2004.

Proxy and surrogate consent in geriatric neuropsychiatric research: Update and recommendations.
Kim S, Appelbaum PS, Jeste DV, Olin J. American Journal of Psychiatry . 161:797-806, 2004.

Potential research participants' views regarding researcher and institutional financial conflicts of interest.
Kim S, Millard RW, Nisbet P, Cox C, Caine ED. Journal of Medical Ethics. 30:73-79, 2004.

Benefits and burdens of placebos in psychiatric research.
Kim S. Psychopharmacology . 171:13-18, 2003.

The sham surgery debate and the moral complexity or risk-benefit analysis.
Kim S. American Journal of Bioethics. 3:66-68, 2003.

Ethics and politics of research involving subjects with impaired decision-making abilities.
Kim S, Karlawish JHT. Neurology. 61:1645-1646, 2003.

Ethical issues in including suicidal individuals in clinical research.
Fisher CB, Pearson JL, Kim S, Reynolds CF. IRB: Ethics & Human Research. 24:9-14, 2002.

Impaired decision-making ability in subjects with Alzheimer's disease and willingness to participate in research.
Kim S, Caine ED, Cox C. American Journal of Psychiatry . 157:797-802, 2002.

Assessing the competence of persons with Alzheimer's disease in providing informed consent for participation in research.
Kim S, Caine ED, Currier GW, Leibovici A, Ryan JM. American Journal of Psychiatry . 158:712-717, 2001.

Press Coverage:

No information found.